Brain-computer interfaces are inching closer to reality! Elon Musk’s Neuralink announced their first successful human implant, potentially paving the way for direct brain-to-device communication.

Building on pre-clinical research and rigorous ethical review, Neuralink’s brain-computer interface takes a leap forward with its first human deployment. This FDA-approved study targets adults (22+) with severe motor limitations caused by spinal cord injury, or ALS, aiming to restore communication and control through brain signals.

Neuralink’s PRIME trial deploys a specialized robot for surgical precision. This robotic system ensures accurate placement of their implant’s thin wires within the brain region responsible for voluntary movement.

Neuralink’s innovative device acts as a brain-to-computer interpreter. By decoding users’ neural signals, it enables direct control of computers and smartphones, bypassing the need for physical movement or cumbersome wires. Sign up to be a part of this revolutionary trial!

Precision meets miniaturization! Neuralink deploys custom-made needles, a mere 10–12 microns wide, to precisely insert implant threads into the cortex with minimal disruption, maximizing biocompatibility.

Neuralink’s quest to merge minds and machines isn’t without its critics. Here’s why

Shadowed by controversy, Neuralink’s animal testing practices have drawn scrutiny. Reports raise concerns about animal welfare, alleging significant distress and the potential for regulatory breaches. Investigations are ongoing, particularly regarding the reported euthanasia of monkeys.

Is Elon Musk overpromising on Neuralink? Lawmakers call for an SEC probe into his statements about the company’s animal testing and potential exaggerations about the implant’s marketability.

Concerns escalated in May 2023, when Representatives Blumenauer and Schiff requested the USDA investigate potential conflicts of interest within the Neuralink animal testing oversight panel. This request followed allegations of bias and raised questions about the objectivity of the animal welfare review process.